Apyx Medical Corp
NASDAQ:APYX
Apyx Medical Corp
Total Equity
Apyx Medical Corp
Total Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Apyx Medical Corp
NASDAQ:APYX
|
Total Equity
$5.8m
|
CAGR 3-Years
-48%
|
CAGR 5-Years
-38%
|
CAGR 10-Years
-13%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Total Equity
$24.2B
|
CAGR 3-Years
11%
|
CAGR 5-Years
10%
|
CAGR 10-Years
14%
|
|
|
Stryker Corp
NYSE:SYK
|
Total Equity
$22.4B
|
CAGR 3-Years
11%
|
CAGR 5-Years
11%
|
CAGR 10-Years
10%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Total Equity
$52.1B
|
CAGR 3-Years
12%
|
CAGR 5-Years
10%
|
CAGR 10-Years
9%
|
|
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
Total Equity
$1.6B
|
CAGR 3-Years
38%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Total Equity
$17.8B
|
CAGR 3-Years
17%
|
CAGR 5-Years
13%
|
CAGR 10-Years
15%
|
|
Apyx Medical Corp
Glance View
Apyx Medical Corp. operates as an energy-based medical technology company. The company is headquartered in Clearwater, Florida and currently employs 272 full-time employees. The firm operates through two segments: Advanced Energy and original equipment manufacturer (OEM). Its Advanced Energy product portfolio consists of its Helium Plasma Technology that is marketed and sold as Renuvion in the cosmetic surgery market and J-Plasma in the hospital surgical market. These product lines consist of a multifunction generator, a handpiece, and a supply of helium gas. Its primary focus is on the cosmetic surgery market, where Renuvion offers plastic surgeons, fascial plastic surgeons and cosmetic physicians the ability to provide controlled heat to the tissue to achieve their desired results. The firm designs, develops, and manufactures electrosurgical equipment by producing generators and related accessories for medical device manufacturers through original equipment manufacturing (OEM) agreements, as well as start-up companies with the need for its energy-based designs.
See Also
What is Apyx Medical Corp's Total Equity?
Total Equity
5.8m
USD
Based on the financial report for Sep 30, 2025, Apyx Medical Corp's Total Equity amounts to 5.8m USD.
What is Apyx Medical Corp's Total Equity growth rate?
Total Equity CAGR 10Y
-13%
Over the last year, the Total Equity growth was -47%. The average annual Total Equity growth rates for Apyx Medical Corp have been -48% over the past three years , -38% over the past five years , and -13% over the past ten years .
